Intercede Group plc

Intercede Group plc is a cybersecurity company dedicated to ensuring digital trust through its expertise in identity, credential management, and secure mobile solutions. Operating across the UK, Europe, the United States, and internationally, the company offers a suite of specialized products. Key among these is MyID, a credential management system designed to facilitate the deployment of cyber-secure digital identities onto various protected devices. For enterprises, MyID Professional delivers an identity management software solution aimed at bolstering security by replacing vulnerable passwords with robust user authentication methods, such as smart cards or USB tokens integrated with public key infrastructure certificates. Large organizations and government bodies benefit from MyID Enterprise, a comprehensive software platform for the broad deployment and administration of digital identities across secure devices. Additionally, MyID PIV provides a tailored software solution for federal agencies to issue and manage secure digital identities for their employees. Intercede serves a broad range of sectors, including government and federal bodies, aerospace and defense, finance and banking, healthcare and critical infrastructure, energy and utilities, manufacturing and industry, and military and police institutions. Founded in 1992, the company was originally known as Optionsilver plc before adopting the name Intercede Group plc in December 2000, and is headquartered in Lutterworth, United Kingdom.

Intercede Group plc trades as IGP.L on LSE. The company is classified in Technology / Software - Application and reports in GBP.

The current profile places the business in Software - Application. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows £17.71M of revenue and £4.05M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Intercede Group plc can be compared against peers such as Bango PLC, Celebrus Technologies plc, Eagle Eye Solutions Group plc, Strix Group Plc, RM plc, SDI Group plc.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of £67.08M, beta of 1.62, and return on equity of +23.8%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

IGP.L currently shows total debt of £619,000 and beta of 1.62. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.intercede.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.